Benefits of aflibercept treatment for age-related macular degeneration patients with good best-corrected visual acuity at baseline

Currently, age-related macular degeneration (AMD) is treated while patients exhibit good best-corrected visual acuity (BCVA). However, previous clinical trials only include patients with poor BCVA. We prospectively analyzed the benefits of intravitreal aflibercept (IVA) treatment for AMD patients ex...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Minami, Sakiko, Nagai, Norihiro, Suzuki, Misa, Kurihara, Toshihide, Sonobe, Hideki, Kamoshita, Mamoru, Uchida, Atsuro, Shinoda, Hajime, Takagi, Hitoshi, Sonoda, Shozo, Sakamoto, Taiji, Tsubota, Kazuo, Ozawa, Yoko
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5758719/
https://ncbi.nlm.nih.gov/pubmed/29311612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-18255-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados